The Latest in Addiction Medicine

Clinical Psychiatry News

Clinical psychoeconomics: Accounting for money matters in psychiatric assessment and treatment

October 10, 2022

Clinical Psychiatry News

Long-acting naltrexone effective in alcohol use disorder

October 5, 2022

Addiction Medicine

Current Psychiatry

More on varenicline

October 3, 2022

Addiction Medicine

Current Psychiatry

Postop analgesia in Saudi Arabia and the United States: A resident’s perspective

October 3, 2022

Clinical Psychiatry News

Safer opioid supply program in Canada helps those who face overdose risks

September 28, 2022

Addiction Medicine

Clinical Psychiatry News

Could a vaccine (and more) fix the fentanyl crisis?

September 28, 2022

Clinical Psychiatry News

Heart failure drug a new treatment option for alcoholism?

September 28, 2022

Addiction Medicine

Clinical Psychiatry News

Minorities hit especially hard by overdose deaths during COVID

September 23, 2022

Addiction Medicine

Clinical Psychiatry News

Urgent need for research into psychedelic therapy for older adults

September 23, 2022

Clinical Psychiatry News

Clozapine may be best choice for cutting SUD risk in schizophrenia

September 13, 2022

Clinical Psychiatry News

Largest-ever study into the effects of cannabis on the brain

September 9, 2022

Clinical Psychiatry News

Psychiatrists’ views on psychoactive drugs clash with U.S. policy

September 8, 2022

Clinical Psychiatry News

DOJ: Indiana nurses allowed controlled substances during opioid recovery

September 6, 2022

Addiction Medicine

Clinical Psychiatry News

Alcohol warning labels need updates to reflect harms: NEJM

September 1, 2022

Current Psychiatry

Laboratory monitoring for patients on buprenorphine: 10 questions

September 1, 2022

Addiction Medicine